Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
John Yu
With
Blaze Bioscience Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
MRI obtained within 30 days of study enrollment documents a measurable lesion consistent with a primary malignant central nervous system tumor for which maximal safe resection is indicated OR MRI obtained within 30 days of study enrollment documents a measurable lesion consistent with a primary schwannoma enhancing tumor in the cerebellopontine angle for which maximal safe resection is indicated.
Adequate renal and liver function
Subjects with prior therapy are eligible provided they have recovered from any acute toxic effects of prior therapy and have sufficient time interval prior to enrollment.
You may not be if
Pregnant, breast-feeding, or planning to conceive a child within 30 days
Ongoing serious medical conditions such that participation in the study could put the subject at increased risk of worsening their condition
Subjects planned to undergo only a diagnostic biopsy procedure, without intent to resect tissue for therapeutic purposes
Subjects for whom radiographic evidence suggests a non-intra-axial primary brain tumor
Clareo Health | Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
